Literature DB >> 18936957

Age differences in biological monitoring of chemical exposure: a tentative description using a toxicokinetic model.

Tomicic Catherine1, Droz Pierre-Olivier.   

Abstract

AIM: Specific factors responsible for interindividual variability should be identified and their contribution quantified to improve the usefulness of biological monitoring. Among others, age is an easily identifiable determinant, which could play an important impact on biological variability.
MATERIALS AND METHODS: A compartmental toxicokinetic model developed in previous studies for a series of metallic and organic compounds was applied to the description of age differences. Young male physiological and metabolic parameters, based on Reference Man information, were taken from preceding studies and were modified to take into account age based on available information about age differences.
RESULTS: Numerical simulation using the kinetic model with the modified parameters indicates in some cases important differences due to age. The expected changes are mostly of the order of 10-20%, but differences up to 50% were observed in some cases.
CONCLUSION: These differences appear to depend on the chemical and on the biological entity considered. Further work should be done to improve our estimates of these parameters, by considering for example uncertainty and variability in these parameters.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936957     DOI: 10.1007/s00420-008-0366-5

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  32 in total

1.  Total and functional hepatic blood flow decrease in parallel with ageing.

Authors:  M Zoli; D Magalotti; G Bianchi; C Gueli; C Orlandini; M Grimaldi; G Marchesini
Journal:  Age Ageing       Date:  1999-01       Impact factor: 10.668

Review 2.  Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.

Authors:  Harvey J Clewell; Justin Teeguarden; Tracy McDonald; Ramesh Sarangapani; Greg Lawrence; Tammie Covington; Robinan Gentry; Annette Shipp
Journal:  Crit Rev Toxicol       Date:  2002-09       Impact factor: 5.635

Review 3.  Invited review: aging and the cardiovascular system.

Authors:  Alberto U Ferrari; Alberto Radaelli; Marco Centola
Journal:  J Appl Physiol (1985)       Date:  2003-12

Review 4.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 5.  Aging biology and geriatric clinical pharmacology.

Authors:  Allan J McLean; David G Le Couteur
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

6.  Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.

Authors:  Harvey J Clewell; P Robinan Gentry; Tammie R Covington; Ramesh Sarangapani; Justin G Teeguarden
Journal:  Toxicol Sci       Date:  2004-03-31       Impact factor: 4.849

Review 7.  Pharmacokinetic basis of age-related changes in sensitivity to toxicants.

Authors:  L S Birnbaum
Journal:  Annu Rev Pharmacol Toxicol       Date:  1991       Impact factor: 13.820

Review 8.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 9.  Toxicokinetics of organic solvents: a review of modifying factors.

Authors:  A Löf; G Johanson
Journal:  Crit Rev Toxicol       Date:  1998-11       Impact factor: 5.635

10.  The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis.

Authors:  D G Le Couteur; A J McLean
Journal:  Clin Pharmacokinet       Date:  1998-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.